Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

BSX Boston Scientific Corporation

90,405

0,545 (0,61%)

Dernière mise à jour : 16:53:23

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/21/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Edward Ludwig

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Boston Scientific (NYSE:BSX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Plus de graphiques de la Bourse Boston Scientific

Boston Scientific (NYSE:BSX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

Plus de graphiques de la Bourse Boston Scientific

Actualités Boston Scientific Corporation

Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace
Mercredi 11 Décembre 2024 ( il y a 2 semaines) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 4 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 2 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lundi 2 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 27 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 26 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 25 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lundi 25 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
Lundi 25 Novembre 2024 ( il y a 4 semaines) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 22 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 22 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 21 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Plus d'articles sur Boston Scientific Corporation

Credit Agricole

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales